Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rössler

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Digestive Diseases (Basel, Switzerland)|August 4, 2021
Advances in Diagnostic and Interventional Radiology in Hepatocellular CarcinomaOsman Öcal, Daniel Rössler, Jens Ricke, et al.
Experimental and Molecular Pathology|December 3, 2014
Melatonin modifies cellular stress in the liver of septic mice by reducing reactive oxygen species and increasing the unfolded protein responseAstrid Kleber, Darius Kubulus, Daniel Rössler, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 28, 2022
ReplyNajib Ben Khaled, Daniel Rössler, Florian P Reiter, et al.
Digestive Diseases (Basel, Switzerland)|October 25, 2021
Current State of Multidisciplinary Treatment in CholangiocarcinomaNajib Ben Khaled, Sven Jacob, Daniel Rössler, et al.
Radiation Oncology (London, England)|July 28, 2023
Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapyMatthias Stechele, Henrike Link, Heidrun Hirner-Eppeneder, et al.
Digestive Diseases (Basel, Switzerland)|May 23, 2024
Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal AblationMuzaffer Reha Ümütlü, Osman Öcal, Daniel Puhr-Westerheide, et al.
Journal of Cancer Research and Clinical Oncology|September 20, 2021
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trialOsman Öcal, Daniel Rössler, Antonio Gasbarrini, et al.
Oncology Research and Treatment|April 24, 2025
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case ReportMarlies Vornhülz, Marianne Angelberger, Simon Sirtl, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based studyNajib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2023
Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based studyNajib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Digestive Diseases (Basel, Switzerland)|August 4, 2021
Advances in Diagnostic and Interventional Radiology in Hepatocellular CarcinomaOsman Öcal, Daniel Rössler, Jens Ricke, et al.
Experimental and Molecular Pathology|December 3, 2014
Melatonin modifies cellular stress in the liver of septic mice by reducing reactive oxygen species and increasing the unfolded protein responseAstrid Kleber, Darius Kubulus, Daniel Rössler, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 28, 2022
ReplyNajib Ben Khaled, Daniel Rössler, Florian P Reiter, et al.
Digestive Diseases (Basel, Switzerland)|October 25, 2021
Current State of Multidisciplinary Treatment in CholangiocarcinomaNajib Ben Khaled, Sven Jacob, Daniel Rössler, et al.
Radiation Oncology (London, England)|July 28, 2023
Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapyMatthias Stechele, Henrike Link, Heidrun Hirner-Eppeneder, et al.
Digestive Diseases (Basel, Switzerland)|May 23, 2024
Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal AblationMuzaffer Reha Ümütlü, Osman Öcal, Daniel Puhr-Westerheide, et al.
Journal of Cancer Research and Clinical Oncology|September 20, 2021
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trialOsman Öcal, Daniel Rössler, Antonio Gasbarrini, et al.
Oncology Research and Treatment|April 24, 2025
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case ReportMarlies Vornhülz, Marianne Angelberger, Simon Sirtl, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based studyNajib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2023
Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based studyNajib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Pageof 2